Note: Ingredients listed on restricted chemical lists
EC/CAS
420-46-2
Name of the chemical
Ethane, 1,1,1-trifluoro
Concentration
52.00%
EC/CAS
354-33-6
Name of the chemical
Ethane, pentafluoro
Concentration
44.00%
EC/CAS
811-97-2
Name of the chemical
1,1,1,2-Tetrafluoroethane
Concentration
4.00%
General Information
Version
1.5
Revision date
2012-08-16
Product name
Genetron 404A
Emergency telephone
Medical (PROSAR): 1-800-498-5701 or +1-651-523-0309
Icons in SDS
Company Information
company name
Honeywell ASCa Inc
GHS Information
Signal word
Warning!
Section 2
SECTION 2: Hazards identification
OSHA Emergency Overview Form : Liquefied gas Color : colourless Odor : weak Hazard Summary Warning! Container under pressure. This product is not flammable at ambient temperatures and atmospheric pressure. Gas reduces oxygen available for breathing. Causes asphyxiation in high concentrations. The victim will not realize that he/she is suffocating. Inhalation may cause central nervous system effects. May cause cardiac arrhythmia. May cause drowsiness and dizziness. Do not breathe vapour. Irritating to eyes and skin. Avoid contact with skin, eyes and clothing. At higher temperatures, (>250 C), decomposition products may include hydrofluoric acid (HF) and carbonyl halides. The ACGIH Threshold Limit Values (2007) for Hydrogen Fluoride are TLV-TWA 0.5 ppm and Ceiling Exposure Limit 2 ppm.
Potential health effects
Skin : Avoid skin contact with leaking liquid (danger of frostbite). May cause frostbite. Irritating to skin. Eyes : Causes serious eye irritation. May cause frostbite. Ingestion
Principle Routes of Exposure
Effects due to ingestion may include: Gastrointestinal discomfort Inhalation : Gas reduces oxygen available for breathing. Causes asphyxiation in high concentrations. The victim will not realize that he/she is suffocating. Inhalation may cause central nervous system effects. May cause cardiac arrhythmia. Vapours may cause drowsiness and dizziness. Chronic Exposure : None known. Carcinogenicity No component of this product present at levels greater than or equal to 0.1% is identified as a known or anticipated carcinogen by NTP IARC or